Rallybio Corporation Common Stock RLYB
Key Stats
- Today's Range
- $16.95 – $17.22
- 50-Day Range
- $15.85 – $17.35
- 52-Week Range
- $3.67 – $17.57
- Volume
- 7K shs
- Average Volume
- 10K shs
- Market Cap
- $90.26 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.02%
- Days to Cover
- 1.00
About Rallybio Corporation Common Stock
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
Related Stocks
Compare head-to-head: RLYB vs LLY·RLYB vs JNJ·RLYB vs ABBV·RLYB vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.